文献速递慢性静脉疾病血液透析通路

维持性血液透析患者上腔静脉狭窄经皮再通后支架置入的疗效与安全性

Stent Placement After Percutaneous Recanalization of Superior Vena Cava Stenosis in Maintenance Hemodialysis Patients.
PubMed 文献 · J Endovasc Ther · 2024-09-28

该前瞻性队列纳入2016年1月至2023年6月因上腔静脉狭窄住院的58例成年维持性血液透析患者,观察经皮钝性/锐性再通联合支架置入的疗效与安全性。再通成功53例(91.38%),支架置入成功率98.1%,中位随访26个月,总体2年血管通路通畅率33.2%。作者认为该策略有效,但需警惕支架移位和心脏压塞等危及生命的并发症。

要点

  • 经皮上腔静脉再通成功率为91.38%(53/58),其中传统再通37例、锐性再通16例。
  • 支架置入成功率为98.1%,覆膜支架14例、裸金属支架38例。
  • 中位随访26个月,总体2年血管通路通畅率33.2%,带 cuff 导管22.2%、动静脉内瘘41.7%(p=0.414)。

核心结论

  • 经皮上腔静脉再通联合支架置入是有效的治疗策略,可为上腔静脉狭窄的维持性血液透析患者提供可用的血管通路。
  • 应注意支架移位和心脏压塞等潜在危及生命的并发症。

研究设计与样本

  • 前瞻性队列研究,纳入2016年1月至2023年6月在一所大学附属三级医院因上腔静脉狭窄住院的成年维持性血液透析患者58例,平均年龄54.79±13.42岁。
  • 研究经机构伦理委员会批准(2015-201),并在http://www.chictr.org.cn注册(注册号:ChiCTR-ONN-16007790)。
  • 观察经皮钝性/锐性上腔静脉再通联合上腔静脉支架置入的疗效与安全性,记录人口学信息、实验室检查、支架置入成功率、手术相关并发症和长期血管通路通畅率。

主要发现

  • 经皮上腔静脉再通成功53例,成功率91.38%,其中传统再通37例、锐性再通16例。
  • 53例接受上腔静脉再通的患者中,14例成功置入覆膜支架、38例置入裸金属支架,支架置入成功率98.1%。
  • 1例患者在支架置入后即刻发生支架移位入心脏,导致术中心脏压塞,经开胸手术成功抢救。
  • 52例患者完成随访,中位随访26个月(带 cuff 导管25例、动静脉内瘘27例),总体2年血管通路通畅率为33.2%(带 cuff 导管22.2%,动静脉内瘘41.7%,p=0.414)。
  • 传统再通组与锐性再通组的2年血管通路通畅率无统计学显著差异(34.1% vs 31.1%,p=0.731),裸金属支架组与覆膜支架组亦无统计学显著差异(38.1% vs 21.4%,p=0.248)。

临床怎么用

  • 作者认为,经皮上腔静脉再通联合支架置入是可为维持性血液透析合并上腔静脉狭窄患者提供可用血管通路的有效治疗策略。
  • 作者指出,应谨慎操作,选择合适尺寸的球囊以避免上腔静脉破裂或支架移位。
  • 作者认为,上腔静脉锐性再通后置入支架是可行的治疗方式,其2年血管通路通畅率与传统再通组相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the efficacy and safety of stent placement after percutaneous recanalization of superior vena cava (SVC) stenosis in maintenance hemodialysis patients. METHODS: Adult maintenance hemodialysis patients hospitalized at a university-affiliated tertiary hospital due to SVC stenosis from January 2016 to June 2023 were prospectively included. The efficacy and safety of percutaneous blunt/sharp SVC recanalization combined with SVC stent placement were observed. The patients' demographic information and laboratory examination data, stent placement success rate, surgery-related complications, and long-term vascular access patency rate were also recorded and analyzed. The study was approved by the institutional ethics committee (2015-201) and registered at http://www.chictr.org.cn (registry number: ChiCTR-ONN-16007790). RESULTS: A total of 58 patients were included in the study with an average age of 54.79±13.42 years. Percutaneous SVC recanalization was successful in 53 cases, with a success rate of 91.38%, including 37 cases of traditional recanalization and 16 cases of sharp recanalization. Among 53 hemodialysis patients who underwent SVC recanalization, 14 patients successfully received covered stents and 38 patients received bare metal stents, achieving a stent placement success rate of 98.1%. One patient encountered stent displacement into the heart immediately after implantation, causing intra-operative cardiac tamponade, who was successfully rescued by thoracotomy. Fifty-two patients were followed-up for median period of 26 months (cuffed catheter: 25 patients, arteriovenous fistula [AVF]: 27 patients). The overall 2-year vascular access patency rate was 33.2% (cuffed catheter: 22.2%, AVF: 41.7%, p=0.414). There was no statistically significant difference in the 2-year vascular access patency rate between the traditional recanalization group and the sharp recanalization group (34.1% vs 31.1%, p=0.731) and between bare metal stent group and covered stent group (38.1% vs 21.4%, p=0.248). CONCLUSION: Percutaneous SVC recanalization with stent placement is an effective treatment strategy that can provide viable vascular access for maintenance hemodialysis patients with SVC stenosis. Cautions should be paid to potential life-threatening complications such as stent displacement and cardiac tamponade.Clinical ImpactSuperior vena cava (SVC) stenosis is a common central venous occlusive lesion in maintenance hemodialysis patients. Whether stent should be implanted simultaneously following SVC recanalization is still lacking research. This pilot cohort study suggested that percutaneous SVC recanalization with stent placement was an effective treatment strategy which provides satisfactory vascular access for hemodialysis. We further found that SVC sharp recanalization with subsequent stent implantation was a feasible treatment, with the 2-year vascular access patency comparable to the traditional SVC recanalization group. This study also highlighted endovascular SVC recanalization should be performed with caution, and appropriate balloon sizes should be selected to avoid SVC rupture or stent displacement.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zhao Y, Liu C, Wei W, et al. Stent Placement After Percutaneous Recanalization of Superior Vena Cava Stenosis in Maintenance Hemodialysis Patients. J Endovasc Ther. 2024. PMID: 39342444. doi:10.1177/15266028241283661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。